Company Announcement no. 3/2015
To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 21 January 2015
Veloxis Pharmaceuticals Announces Updated Financial Calendar for 2015
Veloxis Pharmaceuticals A/S (OMX: VELO) today announces updated financial calendar for 2015.
The annual report 2014 will be released on 3. March 2015 compared to previously announced on 4. March 2015. All other dates are unchanged.
The full updated calendar is shown below.
3. March, 2015: Release of Annual Report 2014.
26 March, 2015: Annual General Meeting.
20 May, 2015: Interim Report for the 1st Quarter ‐ for the period 1 January to 31 March, 2015.
26 August, 2015: Interim Report for the 2nd Quarter – for the period 1 January to 30 June, 2015.
11 November, 2015: Interim Report for the 3rd Quarter – for the period 1 January to 30 September, 2015.
For more information, please contact:
Veloxis Pharmaceuticals A/S
Bill Polvino Johnny Stilou
President & CEO EVP, Chief Financial Officer
Mobile: +1 917 647 9107 Mobile: +45 21 227 227
Email: wjp@veloxis.com Email: jst@veloxis.com
About Veloxis Pharmaceuticals
Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis’ unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.
For further information, please visit www.veloxis.com.
